<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN
        </div>
        <div class="card-body">
                <p>Background: Up to 30% of patients with pediatric inflammatory bowel disease (IBD) do not respond to anti-Tumor Necrosis Factor (anti-TNF) therapy. The aim of this study was to identify pharmacogenomic markers that predict early response to anti-TNF drugs in pediatric patients with IBD. Methods: An observational, longitudinal, prospective cohort study was conducted. The study population comprised 38 patients with IBD aged &lt; 18 years who started treatment with infliximab or adalimumab (29 responders and nine non-responders). Whole gene expression profiles from total RNA isolated from whole blood samples of six responders and six non-responders taken before administration of the biologic and after two weeks of therapy were analyzed using next-generation RNA sequencing. The expression of six selected genes was measured for purposes of validation in all of the 38 patients recruited using qPCR. Results: Genes were differentially expressed in non-responders and responders (32 before initiation of treatment and 44 after two weeks, Log2FC (Fold change) &gt;0.6 or &lt;_0.6 and p value &lt; 0.05). After validation, FCGR1A, FCGR1B, and GBP1 were overexpressed in non-responders two weeks after initiation of anti-TNF treatment (Log2FC 1.05, 1.21, and 1.08, respectively, p value &lt; 0.05). Conclusion: Expression of the FCGR1A, FCGR1B, and GBP1 genes is a pharmacogenomic biomarker of early response to anti-TNF agents in pediatric IBD.</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd>
                    <a href="https://bioregistry.io/msigdb:M41742">M41742</a>
                </dd>

                
                
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<a href="https://bioregistry.io/RO:0002162"><code>RO:0002162</code></a>
)
                    </dt>
                    <dt>
                        <ul>
                                <li><a href="https://bioregistry.io/NCBITaxon:9606"><code>NCBITaxon:9606</code></a>
</li>
                        </ul>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<a href="https://bioregistry.io/BFO:0000051"><code>BFO:0000051</code></a>
)
                    </dt>
                    <dt>
                        <ul>
                                <li><a href="https://bioregistry.io/ncbigene:28424"><code>ncbigene:28424</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:28823"><code>ncbigene:28823</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:28940"><code>ncbigene:28940</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:28452"><code>ncbigene:28452</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:28914"><code>ncbigene:28914</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:28913"><code>ncbigene:28913</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:28408"><code>ncbigene:28408</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:28299"><code>ncbigene:28299</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:28392"><code>ncbigene:28392</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:28883"><code>ncbigene:28883</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:28930"><code>ncbigene:28930</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:3514"><code>ncbigene:3514</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:3493"><code>ncbigene:3493</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:3501"><code>ncbigene:3501</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:28912"><code>ncbigene:28912</code></a>
</li>
                                <li><a href="https://bioregistry.io/ncbigene:3500"><code>ncbigene:3500</code></a>
</li>
                        </ul>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Property</span>
                        category_code
                    </dt>
                    <dt>
                            C2
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Property</span>
                        sub_category_code
                    </dt>
                    <dt>
                            CGP
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Property</span>
                        contributor
                    </dt>
                    <dt>
                            Anthony Castanza
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Property</span>
                        exact_source
                    </dt>
                    <dt>
                            Table 4. List of genes expressed differentially between responders (R) and non-responders (NR) after two weeks of anti-TNF treatment.
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Property</span>
                        external_details_url
                    </dt>
                    <dt>
                            https://www.mdpi.com/1999-4923/13/1/77/htm
                    </dt>
            </dl>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>